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Abstract
Background: To determine whether androgen receptor (AR) CAG (polyglutamine) and GGN (polyglycine) polymorphisms
influence bone mineral density (BMD), osteocalcin and free serum testosterone concentration in young men.
Methodology/Principal Findings: Whole body, lumbar spine and femoral bone mineral content (BMC) and BMD, Dual X-ray
Absorptiometry (DXA), AR repeat polymorphisms (PCR), osteocalcin and free testosterone (ELISA) were determined in 282
healthy men (28.667.6 years). Individuals were grouped as CAG short (CAGS) if harboring repeat lengths of#21 or CAG long
(CAGL) if CAG .21, and GGN was considered short (GGNS) or long (GGNL) if GGN #23 or .23. There was an inverse
association between logarithm of CAG and GGN length and Ward’s Triangle BMC (r =20.15 and 20.15, P,0.05, age and
height adjusted). No associations between CAG or GGN repeat length and regional BMC or BMD were observed after
adjusting for age. Whole body and regional BMC and BMD values were similar in men harboring CAGS, CAGL, GGNS or GGNL
AR repeat polymorphisms. Men harboring the combination CAGL+GGNL had 6.3 and 4.4% higher lumbar spine BMC and
BMD than men with the haplotype CAGS+GGNS (both P,0.05). Femoral neck BMD was 4.8% higher in the CAGS+GGNS
compared with the CAGL+GGNS men (P,0.05). CAGS, CAGL, GGNS, GGNL men had similar osteocalcin concentration as well
as the four CAG-GGN haplotypes studied.
Conclusion: AR polymorphisms have an influence on BMC and BMD in healthy adult humans, which cannot be explained
through effects in osteoblastic activity.
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Introduction
Androgen receptor (AR) are expressed in osteoblasts, osteo-
clasts, and osteocytes [1,2]. Hypogonadism in men is associated
with increased bone turnover and bone loss [3], and it is reverted
by testosterone treatment [4]. However, conflicting results have
been reported regarding the association between testosterone and
bone mineral density (BMD) in older men [5–7]. In men over the
age of 65 years with testosterone levels within the normal range,
lower concentrations of testosterone were not associated with low
bone density [5].
Since some polymorphic variations of the AR confer increased
androgen sensitivity [8,9], differences in the strength of the association
between circulating testosterone and bone mass could be explained by
differences in the polymorphic variation of the ARs [7].
The AR has a variable NH2-terminal domain that contains
two functionally polymorphic microsatellites, a polyglutamine
tract encoded by CAG repeats and a polyglycine tract (GGN)
encoded by (GGT)3GGG(GGT)2(GGC)n repeats [8]. Long
CAG repeats are associated with reduced AR transactivation
activity and weaker transcriptional potential [8], while androgen
responsiveness is increased in cell cultures with short GGN
repeats [9]. However, previous studies on the influence of the
CAG repeat polymorphism on BMD have yield conflicting
results [7,10–12], maybe due to lack of consideration of a
potential interaction between the CAG and GNN repeat
polymorphisms.
Thus we hypothesized that the length of CAG and GNN
polymorphism will be inversely associated to BMD in men and that
CAG and GGN will interact, meaning that men harbouring short
alleles of both CAG and GGN repeats will have greater BMD.
The main purpose of this study was to determine whether
androgen receptor CAG and GGN polymorphisms influence
BMD, bone mineral content (BMC), free serum testosterone
concentration and serum osteocalcin concentration, as a marker of
osteoblastic function, in young men.
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Methods
Subjects
Two-hundred eighty-two men (age: 28.667.6 years; height:
176.865.5 cm; body mass: 78.1610.3 kg; mean 6 SD) partici-
pated in the study (Table 1). They were recruited between
university students, sports clubs and local police officers in Gran
Canaria (Spain). The health status of each participant was
established by a medical history and physical examination.
Subjects under medication or having any chronic disease or
hypertension were excluded.
Ethics Statement
The study was performed in accordance with the Helsinki
Declaration of 1975, last modified in 2000, as regards the conduct
of clinical research, being approved by the Ethical Committee of
the University of Las Palmas de Gran Canaria. All volunteers
provided their written consent before participation in the study.
Blood sampling and body composition analysis
The testing day started with a 20 ml blood sample collection
from an antecubital vein in the supine position, between 7.30 and
8.30 a.m. Afterwards, whole body composition was assessed by
dual-energy X-ray absorptiometry (DXA) (QDR-1500, Hologic
Corp., Software version 7.10, Waltham, MA) as reported
elsewhere [13,14].
Serum free testosterone and osteocalcin determinations
Serum free testosterone and osteocalcin were determined by
Enzyme-Linked Immunosorbent Assay (ELISA) (ELx800 Universal
Microplate Reader, Bioteck Instruments Inc, Vermont, USA), using
reagent kits from IBL (Hamburg, Germany) for free testosterone and
from Nordic Bioscience Diagnostics (Herlev, Denmark) for osteocal-
cin. Low-end sensitivity was 0.17 pg/mL and 0.5 ng/mL for the free
testosterone and osteocalcin, respectively. Intra- and interassay
coefficients of variation were 6.1 and 7.8% for free testosterone, 6.7
and 6.7% for osteocalcin [15,16].
CAG and GGN repeat polymorphisms
DNA was extracted from blood samples (200 ml) using High
Pure PCR Template Preparation Kits (Roche Applied Science).
To determine the length of the CAG and GGN repeats the
corresponding regions located on the exon 1 of the AR gene
(Genbank accession no. M27423) were amplified using two pairs
of primers whose sequence has been previously reported [17]. One
primer from each pair was marked with fluorescent dye (FAM or
VIC). Amplification was performed in a 25 ml reaction volume,
containing 50 ng of genomic DNA, 200 mM of each deoxynucle-
otide triphosphate, 1x Fast Start Taq DNA polymerase Buffer
(Roche Applied Science, Mannheim, Germany), 1x GC-rich
solution buffer (Roche Applied Science) and 1U of Fast Start Taq
DNA polymerase (Roche Applied Science). The concentration of
each pair of primers was 1.2 and 1.5 mM for the amplification of
the CAG and GGN repeats, respectively. PCR conditions were: 30
cycles of 95uC for 45 sec, 56uC for 30 sec and 72uC for 30 sec for
CAG amplification; 30 cycles of 95uC for 1 min, 55uC for 2 min
and 72uC for 2 min for GGN amplification. Each PCR was
initiated with a denaturation step at 95uC for 5 min and
terminated with an extension step at 72uC for 5 min. The PCR
product was diluted 1:100 in distilled water and 1 ml of the dilution
was mixed with 10 ml of formamide and 0.3 ml of GeneScan 500
LIZ Size Standard (Applied Biosystems, Warrington, UK),
denatured at 98uC for 5 min and cooled on ice. Fragment
separation was performed by automated capillary electrophoresis,
using an ABI Prism 3100 Genetic Analyzer (Applied Biosystems)
and the length was determined with Gene Scan Analysis Software
(version 3.7) (Applied Biosystems).
Statistics
All variables were checked for normal distribution by the
Kolmogorov-Smirnov test. Due to non-normal distribution, CAG
and GGN repeat length, osteocalcin and free testosterone were
logarithmically transformed. The influence of CAG and GGN
repeat lengths on bone mineral content and areal density was
determined taking CAG and GGN repeat lengths as either
continuous variables or as dichotomous variables with allele cutoff
thresholds. Individuals were grouped as CAG short (CAGS) if
harboring repeat lengths of #21 and CAG long (CAGL) if
harboring repeat lengths of .21. Subjects were ascribed to the
GGN short (GGNS) group if harboring repeat lengths of #23,
otherwise they were included in the GGN long (GGNL) group.
The median value which resulted in the most balanced grouping
was used as cutoff threshold [14,17]. In addition, the subjects
were also grouped if having any of the following haplotype
combinations: CAGS+CGNL, CAGL+CGNS, CAGL+CGNL and
CAGS+CGNS. Relationships between variables were assessed
calculating the Pearson correlation coefficient (rp) in normally
distributed variables. The Spearman’s correlation coefficient (rs)
was determined to assess potential linkage disequilibrium between
CAG and GGN microsatellites, using the native CAG and GGN
values, which were not normally distributed.
Table 1. Body composition, anthropometrics and physical
activity in men with CAGS and CAGL androgen receptor
polymorphisms (mean 6 standard deviation).
CAGS n CAGL n
Age 28.3 6 7.6 151 29.5 6 7.6 131
Height (years) 176.5 6 5.3 151 177.1 6 5.8 131
Body mass (kg) 77.5 6 9.7 151 78.8 6 10.9 131
Percentage of body fat (%) 19.3 6 6.7 151 19.3 6 8.0 131
Sports history (years) 7.9 6 6.3 145 8.1 6 5.3 128
Hormones
Free Testosterone (pg/mL) 21.1 6 11.3 140 21.1 6 9.6 121
Osteocalcin (ng/mL) 21.2 6 7.3 145 21.4 6 9.0 120
Body composition
Whole body BMC (g) 2985.4 6 321.3 151 2997.9 6 362.0 131
Whole body BMD (g/cm2) 1.2 6 0.1 151 1.2 6 0.1 131
Upper extremities BMC (g) 386.8 6 56.4 151 395.0 6 55.69 131
Upper extremities BMD
(g/cm2)
0.8 6 0.1 151 0.8 6 0.0 131
Lower extremities BMC (g) 1266.1 6 149.8 151 1247.2 6 158.5 131
Lower extremities BMD
(g/cm2)
1.5 6 0.1 151 1.5 6 0.1 131
Femoral neck BMC (g) 6.1 6 0.9 151 5.9 6 1.0 131
Femoral neck BMD (g/cm2) 1.0 6 0.1 151 1.0 6 0.1 131
Ward’s triangle BMC (g) 1.0 6 0.2 151 0.9 6 0.2 131
Ward’s triangle BMD (g/cm2) 0.9 6 0.2 151 0.8 6 0.2 131
BMC: bone mineral content, BMD: bone mineral density. Individuals were
considered as CAG short (CAGS) if harboring repeat lengths #21 and CAG long
(CAGL) if harboring repeat lengths of .21.
doi:10.1371/journal.pone.0011529.t001
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Differences between variables were assessed using ANOVA with
2 factors (CAG and GGN lengths), each with two levels (short and
long repeat number). In addition, we determined differences
between haplotypes using ANOVA with four different haplotype
combinations: CAGS+CGNL, CAGL+CGNS, CAGL+CGNL and
CAGS+CGNS. ANCOVA with age and height as covariates was
also used to account for potential confounding of these two
variable on bone and hormonal variables. Stepwise multiple
regression analysis was used to determine which variables predict
femoral neck BMD.
Results
Subject’s body composition and anthropometrics is reported in
Table 1. Androgen receptor CAG and GGN repeat lengths were
not correlated (Spearman’s correlation=20.05, P = 0.43) (Spear-
man’s correlation =20.03, P= 0.79), indicating lack of linkage
disequilibrium between CAG and GGN microsatellites.
CAG repeat polymorphism
There was an inverse association between the logarithm of the
CAG repeat length and femoral neck BMC, Ward’s Triangle
BMC and Ward’s Triangle BMD (rp =20.12, 20.14 and 20.12,
P,0.05). However, after adjusting for age and height, only the
association between the logarithm of the CAG repeat length and
Ward’s Triangle BMC remained significant (r =20.15, P,0.05).
In the other skeletal regions studied, men with CAGS had BMC
and BMD values similar to CAGL men (Table 1).
GGN repeat polymorphism
No associations between GGN length and regional BMC or BMD
were observed. However, after adjusting for age and height there was
and inverse association between the logarithm of GGN length and
Ward’s Triangle BMC (r=20.15, P,0.05). Regional BMC and
BMD were similar between the GGNS and GGNL groups (Table 2).
CAG and GGN repeat polymorphisms haplotypes
Whole body BMC and BMD were similar in the four CAG-
GGN haplotypes studied (Fig. 1). Men harboring the combination
CAGL+GGNL had 6.3% higher lumbar spine BMC than men
with the haplotype CAGS+GGNS (P,0.05) (Fig. 2). Likewise, men
with the haplotype CAGL+GGNL had 4.4 and 4.3% higher
lumbar spine BMD than men harboring the combinations
CAGS+GGNS and CAGL+GGNS, respectively (both P,0.05)
(Fig. 2). Men with the combination CAGS + GGNS had 13.8, 11.7
and 7.2% higher Ward’s Triangle BMC than those with the
combinations CAGL+GGNL, CAGS+GGNL, and CAGL+GGNS,
respectively (all P,0.05) (Fig. 3). Ward’s Triangle BMD was 9.8,
7.9 and 6.9% higher in men with CAGS+GGNS compared to
CAGL+GGNL, CAGS+GGNL, and CAGL+GGNS, respectively
(all P,0.05) (Fig. 3). Femoral neck BMD was 4.8% higher in the
CAGS+GGNS compared with the CAGL+GGNS men (P,0.05)
(Fig. 3). The mean BMD of the lower extremities was 2.4% higher
in the CAGS+GGNS compared with the CAGL+GGNS men
(P,0.05) (Fig. 4). All these between-haplotypes differences in
regional BMD and BMC remained statistically significant after
accounting for height and age as covariates.
Free testosterone bone mass and androgen receptor
polymorphism
There was no relationship between either CAG or GGN repeats
length and free testosterone, even after adjusting for age. Basal
serum free testosterone concentrations were similar in CAGS and
CAGL (21.1611.3 and 21.169.6 pmol/L, respectively P= 0.43).
Although free testosterone concentration was 13% higher in
GGNS compared to GGNL this difference did not reach statistical
significance (22.1611.2 and 19.669.3 pmol/L, respectively,
P= 0.07). There were significant associations between the
logarithm of free testosterone concentration and BMC at the
whole body, femoral neck, Ward’s Triangle, and lower extremities
(rp = 0.15, 0.21, 0.18, and 0.12, respectively, P,0.05). The
logarithm of free testosterone concentration was also associated
to BMD at the femoral neck, Intertrochanteric region, Greater
trochanter, Ward’s Triangle, and lower extremities (rp = 0.21,
0.13, 0.20, 0.22, and 0.17, respectively, all P,0.05). However,
after adjusting for age there was no association between the
logarithm of free testosterone concentration and regional or whole
body BMC and BMD.
Free testosterone concentrations were similar across the four
haplotypes (i.e., 20.169.1, 22.4612.4, 19.369.5, and 21.7610.0, for
CAGL+CGNL, CAGs+CGNs, CAGs+CGNL, and CAGL+CGNs,
respectively).
Androgen receptor polymorphisms and osteoblastic
function
There was no relationship between either CAG or GGN
repeats length and osteocalcin. As shown in Table 1, serum
osteocalcin concentrations were similar in CAGS and CAGL
(Table 1) as well as in GGNS and GGNL subjects (Table 2).
Osteocalcin concentrations were also similar across the four
haplotypes (data not shown). However, there were significant
correlations between osteocalcin and: free testosterone, BMC at
femoral neck, greater trochanter, intertrochanteric area, Ward’s
Table 2. Body composition, anthropometrics and physical
activity in men with GGNS and GGNL androgen receptor
polymorphisms (mean 6 standard deviation).
GGNS n GGNL n
Age 28.7 6 7.1 170 29.1 6 8.4 112
Height (cm) 176.6 6 5.5 170 177.1 6 5.6 112
Body mass (kg) 77.5 6 9.8 170 79.1 6 10.9 112
Percentage of body fat (%) 19.0 6 6.9 170 19.7 6 7.9 112
Sports history (years) 7.8 6 5.9 165 8.3 6 5.8 108
Hormones
Free Testosterone (pg/mL) 22.1 6 11.2 158 19.6 6 9.3 103
Osteocalcin (ng/mL) 21.4 6 8.4 160 21.3 6 7.7 105
Body composition
Whole body BMC (g) 2969 6 27 170 3024 6 31 112
Whole body BMD (g/cm2) 1.24 6 0.01 170 1.25 6 0.01 112
Upper extremities BMC (g) 387 6 56 170 395 6 56 112
Upper extremities BMD (g/cm2) 1248 6 158 170 1272 6 147 112
Lower extremities BMC (g) 0.83 6 0.05 170 0.84 6 0.05 112
Lower extremities BMD (g/cm2) 1.47 6 0.12 170 1.47 6 0.10 112
Femoral neck BMC (g) 6.0 6 0.1 170 6.1 6 0.1 112
Femoral neck BMD (g/cm2) 1.04 6 0.01 170 1.02 6 0.01 112
Ward’s triangle BMC (g) 1.0 6 0.0 170 0.9 6 0.0 112
Ward’s triangle BMD (g/cm2) 0.89 6 0.01 170 0.85 6 0.01 112
BMC: bone mineral content, BMD: bone mineral density. Subjects were
considered as GGN short (GGNS) if harboring repeat lengths #23 and GGN long
(GGNL) if harboring repeat lengths .23.
doi:10.1371/journal.pone.0011529.t002
Androgen Receptor and Bone
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Figure 1. Whole body bone mineral content (BMC) and bone mineral areal density (BMD). Subjects were grouped as CAG short (CAGS) if
harboring repeat lengths of #21 and CAG long (CAGL) if harboring repeat lengths of .21. The cutoff point for GGN short (GGNS) was GGN repeat
polymorphism #23, otherwise subjects were included in the GGN long (GGNL) group. Four haplotypes combinations were defined as: CAGL + GGNL,
CAGS + GGNS, CAGS + GGNL, and CAGL + GGNS.
doi:10.1371/journal.pone.0011529.g001
Figure 2. Mean lumbar spine (from L2, L3 and L4) bone mineral content (BMC) and bone mineral areal density (BMD). Subjects were
grouped as CAG short (CAGS) if harboring repeat lengths of#21 and CAG long (CAGL) if harboring repeat lengths of.21. The cutoff point for GGN short
(GGNS) was GGN repeat polymorphism#23, otherwise subjects were included in the GGN long (GGNL) group. Four haplotypes combinations were defined
as: CAGL + GGNL, CAGS + GGNS, CAGS + GGNL, and CAGL + GGNS. * P,0.05 compared to CAGS + GGNS; 1 P,0.05 compared to CAGL + GGNS.
doi:10.1371/journal.pone.0011529.g002
Androgen Receptor and Bone
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Triangle, BMD at whole body, femoral neck, greater trochanter,
intertrochanteric area, (rp = 0.23, 0.27, 0.19, 0.28, 0.13, 0.31,
0.32 and 0.23, respectively, P,0.05). All these correlations were
not significant after adjusting for age, due to the negative
correlation between the logarithm of osteocalcin and age
(rp =20.57, P,0.01).
Discussion
This study indicates that androgen receptor polymorphisms
have an influence on bone mass and density in healthy adult men.
These associations showed regional specificity, implying that the
relationship between androgen receptor polymorphisms and bone
Figure 3. Hip bone mineral content (BMC) and bone mineral areal density (BMD). Subjects were grouped as CAG short (CAGs) if harboring
repeat lengths of#21 and CAG long (CAGL) if harboring repeat lengths of.21. The cutoff point for GGN short (GGNs) was GGN repeat polymorphism
#23, otherwise subjects were included in the GGN long (GGNL) group. Four haplotypes combinations were defined as: CAGL + GGNL, CAGS + GGNS,
CAGS + GGNL, and CAGL + GGNS. * P,0.05 compared to CAGS + GGNS; 1 P,0.05 compared to CAGL + GGNS.
doi:10.1371/journal.pone.0011529.g003
Androgen Receptor and Bone
PLoS ONE | www.plosone.org 5 July 2010 | Volume 5 | Issue 7 | e11529
mass is modulated, and in some instances overridden, by other
endocrine variables and local factors. We have found an inverse
association between CAG and GGN repeat length and Ward’s
Triangle BMC. However, the most interesting aspect of this study
is that it shows that there is a regional specificity in the relationship
between the CAG and GGN polymorphisms and bone mass. In
contrast with our hypothesis, men with CAGL+GGNL haplotypes,
which potentially have lower androgen responsiveness, have
greater BMC and BMD at the lumbar spine than men harboring
CAGS+GGNS haplotypes. However, femoral neck BMD was
higher in men with CAGS+GGNS compared with CAGL+GGNS
haplotypes.
Bone mass and androgen receptor CAG and GNN repeat
polymorphism
When CAG and GGN polymorphism were considered separately,
after adjusting for age and height, no association between CAG and
GGN length and bone mineral density was observed in the present
investigation. The influence of GGN repeat AR polymorphism on
bone mass and density has not been studied previously and, hence, we
can not compare our results with other studies. Conflicting results have
been reported regarding the influence of CAG repeat length on BMD.
In agreement with our results, lack of association between CAG repeat
length and BMD has been reported in middle aged [12] and aged men
[18]. However, a positive association between BMD of the lumbar
spine and femoral neck with length of the CAG repeat polymorphism
has also been reported in men over the age of 40 years [7,11].
Some of these discrepancies just reflect a polygenic influence on
bone mass and the impact of a number of factors, such as, age,
gender, nutrition, race, life style, mechanical loading, skeletal
region under consideration among others, which are known to
influence bone metabolism [5,19–22]. This is further underlined
by the fact that even studies in the same population, for example
Scandinavians, but carried out in different countries have yield
different results [7,10–12]. In the studies in which an association
have been found between CAG repeat length polymorphism and
BMD, its strength has consistently been rather low, i.e., CAG
repeat length polymorphism can only explain a rather small part
of the variance in BMD, and only in some specific regions. Thus,
other factors influencing BMD prevail on CAG repeat polymor-
phism in many instances.
Free testosterone and androgen receptor polymorphism
Previous studies have reported lack of association between CAG
repeat number and free testosterone in middle-aged [7,23] and
aged men [18]. The present investigation shows that also in young
adult men there is no association between CAG or GGN length
and free testosterone levels. As expected, there was a positive
association between free testosterone levels and bone mass and
density in men [6]. However, this association was not statistically
significant after adjusting for age.
A relationship between serum testosterone levels and CAG
repeat length and femoral BMD has been recently reported in
healthy Swedish men [7]. These authors observed that men having
the combination of low free testosterone and shorter CAG repeat
length had the lower femoral neck BMD [7]. After adjusting for
age we could not confirm this association between free
testosterone, CAG repeat length and femoral neck BMD. A part
from the different age of the populations, racial and environmental
differences could also explain the discrepancies.
Osteocalcin and androgen receptor polymorphisms
Although androgen receptors repeat polymorphisms have an
influence on BMC and BMD in healthy adult humans, this could
Figure 4. Bone mineral content (BMC) and areal bone mineral density (BMD) of the upper and lower extremities. Subjects were grouped as
CAG short (CAGS) if harboring repeat lengths of#21 and CAG long (CAGL) if harboring repeat lengths of.21. The cutoff point for GGN short (GGNS) was
GGN repeat polymorphism#23, otherwise subjects were included in the GGN long (GGNL) group. Four haplotypes combinations were defined as: CAGL +
GGNL, CAGS + GGNS, CAGS + GGNL, and CAGL + GGNS. * P,0.05 compared to CAGS + GGNS; $ P,0.05 compared to CAGL + GGNL.
doi:10.1371/journal.pone.0011529.g004
Androgen Receptor and Bone
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not be explained by differences in osteoblastic activity. In
concordance with our results, Valimaki et al [24], measured
markers of bone turnover in a cohort of males with similar ages as
ours (18–21yrs), and did not find any difference between
individuals carrying either short or long CAG repeat lengths.
However, the mean CAG repetition number for this cohort was
28, whereas it was 22 in the present investigation, making
comparisons between both studies difficult. Additional studies
carried out in elders showed no relationship between CAG repeat
length and C-terminal telopeptide of the type I collagen,
osteocalcin, BSAP and urinary deoxypirindoline [18,25]. To our
knowledge, there are no data available about the influence of
GGN repeats on BMD and bone formation/resorption markers
precluding any comparisons of our study with previous investiga-
tions.
In summary this study shows that there is an association
between CAG (and to lesser extend GGN) androgen receptors
polymorphisms and bone mass and bone mineral density, which is
modulated depending on the age and osteocalcin and free
testosterone serum concentrations. Femoral neck BMD is higher
in men with CAGS+GGNS haplotypes, whilst men harboring
CAGL+GGNL haplotypes have the higher lumbar spine BMC and
BMD.
Acknowledgments
The authors thank Jose´ Navarro de Tuero for his excellent technical
assistance.
Author Contributions
Conceived and designed the experiments: AGG JGPG CD HO BNDC
JALC. Performed the experiments: AGG JGPG CD HO TF JPG JSM
BNDC JALC. Analyzed the data: AGG FGRG JGPG CD HO JPG JSM
BNDC JALC. Contributed reagents/materials/analysis tools: AGG FGRG
JGPG CD HO TF JPG JSM BNDC JALC. Wrote the paper: AGG FGRG
JGPG CD BNDC JALC.
References
1. Abu EO, Horner A, Kusec V, Triffitt JT, Compston JE (1997) The localization
of androgen receptors in human bone. J Clin Endocrinol Metab 82: 3493–3497.
2. Pederson L, Kremer M, Judd J, Pascoe D, Spelsberg TC, et al. (1999) Androgens
regulate bone resorption activity of isolated osteoclasts in vitro. Proc Natl Acad
Sci U S A 96: 505–510.
3. Finkelstein JS, Klibanski A, Neer RM, Greenspan SL, Rosenthal DI, et al.
(1987) Osteoporosis in men with idiopathic hypogonadotropic hypogonadism.
Ann Intern Med 106: 354–361.
4. Finkelstein JS, Klibanski A, Neer RM, Doppelt SH, Rosenthal DI, et al. (1989)
Increases in bone density during treatment of men with idiopathic hypogonad-
otropic hypogonadism. J Clin Endocrinol Metab 69: 776–783.
5. Slemenda CW, Longcope C, Zhou L, Hui SL, Peacock M, et al. (1997) Sex
steroids and bone mass in older men. Positive associations with serum estrogens
and negative associations with androgens. J Clin Invest 100: 1755–1759.
6. Greendale GA, Edelstein S, Barrett-Connor E (1997) Endogenous sex steroids
and bone mineral density in older women and men: the Rancho Bernardo
Study. J Bone Miner Res 12: 1833–1843.
7. Stiger F, Brandstrom H, Gillberg P, Melhus H, Wolk A, et al. (2008) Association
Between Repeat Length of Exon 1 CAG Microsatellite in the Androgen
Receptor and Bone Density in Men is Modulated by Sex Hormone Levels.
Calcif Tissue Int.
8. Lee DK, Chang C (2003) Endocrine mechanisms of disease: Expression and
degradation of androgen receptor: mechanism and clinical implication. J Clin
Endocrinol Metab 88: 4043–4054.
9. Ding D, Xu L, Menon M, Reddy GP, Barrack ER (2005) Effect of GGC
(glycine) repeat length polymorphism in the human androgen receptor on
androgen action. Prostate 62: 133–139.
10. Salmen T, Heikkinen AM, Mahonen A, Kroger H, Komulainen M, et al. (2003)
Relation of androgen receptor gene polymorphism to bone mineral density and
fracture risk in early postmenopausal women during a 5-year randomized
hormone replacement therapy trial. J Bone Miner Res 18: 319–324.
11. Langdahl BL, Stenkjaer L, Carstens M, Tofteng CL, Eriksen EF (2003) A CAG
repeat polymorphism in the androgen receptor gene is associated with reduced
bone mass and increased risk of osteoporotic fractures. Calcif Tissue Int 73:
237–243.
12. Remes T, Vaisanen SB, Mahonen A, Huuskonen J, Kroger H, et al. (2003)
Aerobic exercise and bone mineral density in middle-aged finnish men: a
controlled randomized trial with reference to androgen receptor, aromatase, and
estrogen receptor alpha gene polymorphisms small star, filled. Bone 32:
412–420.
13. Sanchis-Moysi J, Idoate F, Olmedillas H, Guadalupe-Grau A, Alayon S, et al.
(2009) The upper extremity of the professional tennis player: muscle volumes,
fiber-type distribution and muscle strength. Scand J Med Sci Sports 20:
524–534.
14. Guadalupe-Grau A, Rodriguez-Gonzalez G, Dorado C, Olmedillas H,
Fuentes T, et al. (2009) Androgen receptor gene polymorphisms lean mass
and performance in young men. Br J Sports Med;In press doi: 10.1136/
bjsm.2009.060285.
15. Guerra B, Fuentes T, Delgado-Guerra S, Guadalupe-Grau A, Olmedillas H,
et al. (2008) Gender dimorphism in skeletal muscle leptin receptors, serum leptin
and insulin sensitivity. PLoS ONE 3: e3466.
16. Guadalupe-Grau A, Perez-Gomez J, Olmedillas H, Chavarren J, Dorado C,
et al. (2009) Strength training combined with plyometric jumps in adults: sex
differences in fat-bone axis adaptations. J Appl Physiol 106: 1100–1111.
17. Rodriguez G, Bilbao C, Ramirez R, Falcon O, Leon L, et al. (2006) Alleles with
short CAG and GGN repeats in the androgen receptor gene are associated with
benign endometrial cancer. Int J Cancer 118: 1420–1425.
18. Van Pottelbergh I, Lumbroso S, Goemaere S, Sultan C, Kaufman JM (2001)
Lack of influence of the androgen receptor gene CAG-repeat polymorphism on
sex steroid status and bone metabolism in elderly men. Clin Endocrinol (Oxf) 55:
659–666.
19. Pocock NA, Eisman JA, Hopper JL, Yeates MG, Sambrook PN, et al. (1987)
Genetic determinants of bone mass in adults. A twin study. J Clin Invest 80:
706–710.
20. Slemenda CW, Christian JC, Williams CJ, Norton JA, Johnston CC, Jr. (1991)
Genetic determinants of bone mass in adult women: a reevaluation of the twin
model and the potential importance of gene interaction on heritability estimates.
J Bone Miner Res 6: 561–567.
21. Soroko SB, Barrett-Connor E, Edelstein SL, Kritz-Silverstein D (1994) Family
history of osteoporosis and bone mineral density at the axial skeleton: the
Rancho Bernardo Study. J Bone Miner Res 9: 761–769.
22. Vicente-Rodriguez G, Dorado C, Ara I, Perez-Gomez J, Olmedillas H, et al.
(2007) Artistic versus rhythmic gymnastics: effects on bone and muscle mass in
young girls. Int J Sports Med 28: 386–393.
23. Krithivas K, Yurgalevitch SM, Mohr BA, Wilcox CJ, Batter SJ, et al. (1999)
Evidence that the CAG repeat in the androgen receptor gene is associated with
the age-related decline in serum androgen levels in men. J Endocrinol 162:
137–142.
24. Valimaki VV, Piippo K, Valimaki S, Loyttyniemi E, Kontula K, et al. (2005)
The relation of the XbaI and PvuII polymorphisms of the estrogen receptor gene
and the CAG repeat polymorphism of the androgen receptor gene to peak bone
mass and bone turnover rate among young healthy men. Osteoporos Int 16:
1633–1640.
25. Zitzmann M, Brune M, Kornmann B, Gromoll J, Junker R, et al. (2001) The
CAG repeat polymorphism in the androgen receptor gene affects bone density
and bone metabolism in healthy males. Clin Endocrinol (Oxf) 55: 649–657.
Androgen Receptor and Bone
PLoS ONE | www.plosone.org 7 July 2010 | Volume 5 | Issue 7 | e11529
